SINOMED Concludes Enrollment of the PIONEER III Randomized, Pivotal Study of the BuMA Supreme Coronary Drug-Eluting Stent
sinomed_ynv81y2021-05-17T17:51:49+08:002019-7-25
About sinomed_ynv81y
This author has not yet filled in any details.So far sinomed_ynv81y has created 31 blog entries.
Exploration Into Early Functional Healing – The latest results of PIONEER global stuties were released at EuroPCR 2018
sinomed_ynv81y2019-06-11T08:43:52+08:002018-6-19
Latest Results of PIONEER Global Studies Released at TCT 2017
sinomed_ynv81y2019-06-11T06:47:32+08:002017-11-21
SINOMED Receives CE Mark Approval for Balloon Catheters: Tytrak™, NC Thonic™ and Sleek Prime
sinomed_ynv81y2019-12-02T10:20:28+08:002017-6-20
PANDA III: 2-years proven superiority in definite/probable stent thrombosis, released on CIT2017
sinomed_ynv81y2019-06-11T08:56:42+08:002017-6-1
The latest progress of AccuFit™ , SINOMED TMVR, released on EuroPCR2016
sinomed_ynv81y2019-06-11T09:03:15+08:002016-6-14
PIONEER Global Trial Strategy of BuMA Supreme™ Released on CIT2016
sinomed_ynv81y2019-06-13T01:11:25+08:002016-4-25
Is less strut coverage linked with a greater rate of stent thrombosis? 1 year result of PANDA III revealed during TCT 2015
sinomed_ynv81y2019-06-13T09:37:04+08:002015-10-24
SINOMED’s TMVR (AccuFit™) introduced during TVT in Chicago!
sinomed_ynv81y2019-06-13T05:17:39+08:002015-6-15
SINOMED Releases Its Exciting Trial and Novel Devices at EuroPCR2015
sinomed_ynv81y2019-06-12T04:47:15+08:002015-5-30